2219 Intratumoral injection of the oncolytic immunotherapeutic Pexa-Vec (JX-594) in liver tumors and hepatocellular carcinoma: Recommendations for clinical practice. (September 2015) - Lencioni, R.; Kim, C.W.; Rose, S.C.; Breitbach, C.J.; Burke, J.M.; Hickman, T.; Kirn, D.H.; Stojkowitz, N.; Lusky, M.; Homerin, M.